ASM Microbe Conference

Jason Pogue, PharmD, BCPS-ID, Clinical Pharmacist, Infectious Diseases, Sinai-Grace Hospital, explains why Pseudomonas aeruginosa is one of the World Health Organization’s critical priority pathogens for new research and development priorities.

Davey Legendre, PharmD, MBA, BCPS, sheds light on the prevalence of confirmed beta-lactam allergies in patients.

Benjamin Young, MD, PhD, shares how many catalysts for the HIV epidemic exist within cities.

Genovefa Papanicolaou, MD, explains in which patient population is CMV most harmful.

The impact of viruses on community-acquired pneumonia seems to be greater than initially realized and the use of procalcitonin may help distinguish infection type for appropriate treatment.

Contagion® sat down with Rodrigo Mendes, PhD, to discuss research exploring evolving resistance among antibiotics to treat skin infections.

Kirk Hevener, PharmD, PhD, explains the drawbacks of first-line drugs that are currently used to treat C. difficile infections.

The weekly Business Watch includes the latest industry news that practitioners working in infectious diseases need to know.

Genovefa Papanicolaou, MD, provides a brief overview of cytomegalovirus.

Conan MacDougall, PharmD, MAS, BCPS-AQ ID, sheds light on behavior change interventions that could positively affect antibiotic prescribing practices.

Thomas File, MD, MSc explains what pleuromutilin antibiotics are and how they work.

Julian Hurdle, PhD explains why some patients experience recurrence of Clostridium difficile after treatment.

Alan Gross, PharmD, BCPS-AQID, explains how antimicrobial stewardship programs need to be strengthened in long-term care facilities.

Niaz Banaei, MD, discusses some reasons why healthcare-associated C. difficile tends to be over-diagnosed.

Researchers describe how government and pharmaceutical companies develop are working to develop new drugs for emerging infectious diseases.

Romney Humphries, PhD, D(ABMM) sat down with Contagion® to discuss the process for receiving clearance on antimicrobial susceptibility tests in the United States.

ASM member Kate Rubins, PhD, first individual to sequence DNA in space, shed light on her experience as a NASA astronaut in a keynote conversation at the ASM Microbe 2017 meeting in New Orleans, Louisiana.

In an interview, David Aranoff, MD, FIDSA from Vanderbilt University, discussed his latest research on infectious diseases and reproductive health.

In an interview at the ASM Microbe 2017 meeting, held in New Orleans, Louisiana, Vice-Chair David Relman, MD, discussed with Contagion® microbiome research and its potential utility in medicine.

At the recent ASM Microbe 2017 Conference, Dr. Robert Bonomo shared with attendees highlights of his long-standing career and achievements.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains the importance of antimicrobial susceptibility testing.

Through the use of citizen science, researchers were able to identify the distribution of ticks and tick-borne diseases in a particularly hyperendemic region of the United States.

Otto Schwake, PhD, explains what led him to suspect automobile windshield washer fluid as a potential source of transmission for Legionella.

Melissa B. Miller, PhD and Robin Patel, MD sat down with Contagion® to discuss how they believe that molecular-based point of care laboratory testing will revolutionize healthcare.

Is it time to reassess prescribing practices on beta-lactams when it comes to patients with penicillin allergies? The answer is an unquestionable, “Yes!” according to Meghan Jeffres, PharmD.

Meghan Jeffres, PharmD, explains why practitioners need to think about the rate of cross-reactivity between antibiotic penicillin and specific cephalosporins.

In New Orleans, The American Society of Microbiology 2017 annual meeting started with 3 distinct speakers.

Conan MacDougall, PharmD, discusses how behavioral change interventions can positively impact the antibiotic prescribing environment.

Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, sat down with Contagion™ to discuss antimicrobial susceptibility and resistance and new technologies in the field.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses push and pull incentives that drive antibiotic development.